India  

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla

DNA Sunday, 20 December 2020
Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Adar Poonawalla Indian businessman

Serum fire losses pegged at over Rs 1,000 crore; Covid vaccine supplies safe

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said its manufacturing plant at Manjari here suffered a loss of over Rs1,000 crore in Thursday’s..
IndiaTimes
Fire has no impact on 'Covishield' vaccine production: Serum Institute of India [Video]

Fire has no impact on 'Covishield' vaccine production: Serum Institute of India

Serum Institute of India (SII) CEO Adar Poonawalla on January 22 informed that there is no impact of fire on the production of 'Covishield' vaccine. "The extent of the damage is more than 1,000 crores. The supply of COVID-19 will not be affected due to the fire (at Serum Institute of India facility). No actual vaccine was being made at that facility. The fire has no impact on the production of 'Covishield' vaccine and no damage has occurred to the existing stock either," said Adar Poonawalla. A major fire had occurred at Pune-based Serum Institute of India (SII) on January 21 that claimed 5 lives also.

Credit: ANI    Duration: 01:16Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka [Video]

Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka

India once again established its position as a reliable partner in Covid-19 assistance. It dispatched Covishield to Bahrain and Sri Lanka under the Vaccine Maitri Initiative. Sri Lanka to receive a consignment of 50,400 doses, while Bahrain to get 10,800 doses. Covishield developed by Serum Institute of India was loaded to cargo aircraft at Mumbai. The cargo aircraft left Mumbai airport as per schedule at 7:55 am for Manama. The vaccine consignment for Colombo, which delayed for 15 minutes, left at 9:00 am. Meanwhile, India has supplied vaccines to its neighbours under neighbourhood first policy. Bhutan, Maldives, Nepal, Myanmar, Sri Lanka, Afghanistan, Bangladesh received vaccines. India sees international cooperation in the area of fight against Covid-19 as its duty. New Delhi has played the role of the first responder in the region.

Credit: HT Digital Content    Duration: 01:29Published

India's gift of 5 lakh doses of Covid-19 vaccines reach Sri Lanka

Sri Lanka's president on Thursday welcomed the first 500,000 doses of a Covid-19 vaccine from India, which has donated the shots to eight countries in the..
IndiaTimes
SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo [Video]

SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo

Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 28. The consignment containing COVID-19 vaccine will be dispatched to Bahrain and Colombo today. India is helping other countries with the import of COVID vaccine amid the pandemic.

Credit: ANI    Duration: 01:41Published

Related videos from verified sources

Serum Institute fire: 5 killed, 6 rescued; PM Modi expresses anguish [Video]

Serum Institute fire: 5 killed, 6 rescued; PM Modi expresses anguish

Cyrus S Poonawalla, chairman and MD of Serum Institute of India, on Thursday said the vaccine major will offer compensation of Rs 25 lakh in addition to the mandated amount to families of persons who..

Credit: HT Digital Content     Duration: 03:00Published
Watch: SII CEO Poonawalla receives shot of Covishield vaccine [Video]

Watch: SII CEO Poonawalla receives shot of Covishield vaccine

Serum Institute of India (SII), CEO Adar Poonawalla received a COVISHIELD vaccine shot on January 16. COVISHIELD vaccine is manufactured by SII. India has approved 2 vaccines - Covishield and Covaxin...

Credit: ANI     Duration: 01:08Published
Release of first consignment of Covishield brings cheer to SII employees [Video]

Release of first consignment of Covishield brings cheer to SII employees

Employees and CEO-owner of Serum Institute of India (SII) Adar Poonawalla applauded at their office in Pune, as the first consignment of Covishield was dispatched across India on January 12.

Credit: ANI     Duration: 01:10Published

Related news from verified sources

Mumbai: Is a vaccine even needed for COVID, Citizens group question

Mumbai: Is a vaccine even needed for COVID, Citizens group question
Even as the nation waits for a COVID-19 vaccine with bated breath, the recently formed citizens' movement group, Awaken India, put forward a question - Is a...
Mid-Day Also reported by •IndiaTimes

Sputnik V from Russia arrives in India for clinal trials

Sputnik V, the first registered Covid-19 vaccine from Russia arrived in India on Tuesday for clinical trials. Russian Direct Investment Fund (RDIF) and Dr...
Mid-Day Also reported by •IndiaTimes

Russia will jointly produce Sputnik V vaccine with India: Envoy

Russian envoy in New Delhi Nikolay Kudashev on Monday said Moscow will jointly produce the Sputnik V vaccine for Covid-19 along with India and it will be...
IndiaTimes Also reported by •Zee NewsMid-Day